Oncogene

As per available reports about 100 journals, 162 Conferences, 30 workshops are presently dedicated exclusively to Oncogene and about 366282 articles are being published on the current trends in Oncogene. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to proteomics are being carried out. Oncogene is the gene having potential to cause cancer.

With the increased expressions, it transforms to further more potent genes ultimately leading to cancer. The cell growth and differentiation are generally stimulated by the proteins or steroids. The Journal of Integrative Oncology is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in Oncogene. Each year research scientists have noticed a rise in the number of congresses being held in this field.

The Journal of Integrative Oncology provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of Oncogene, thus bridging the gap between researchers and young scientists. With the overwhelming success of previous annual Cancer Science conferences, OMICS Group officially welcomes the scientific community to attend the 4th World Congress on Cancer Science & Therapy, during October 20-22, 2014 at Chicago, USA.